K172937 is an FDA 510(k) clearance for the Colorado Therapeutics Xenograft Implant. Classified as Mesh, Surgical (product code FTM), Class II - Special Controls.
Submitted by Colorado Therapeutics, LLC (Bloomfield, US). The FDA issued a Cleared decision on October 25, 2017 after a review of 29 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3300 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.